MYBPC1 Gene Lethal Congenital Contracture Syndrome Type 4 Genetic Test
Welcome to DNA Labs UAE, where we offer the MYBPC1 Gene Lethal Congenital Contracture Syndrome Type 4 Genetic Test. This test is designed to help diagnose and provide information for genetic counseling, family planning, and potential treatment options.
Test Details
The MYBPC1 gene is associated with a condition called lethal congenital contracture syndrome type 4 (LCCS4). LCCS4 is a rare genetic disorder characterized by multiple joint contractures, which restrict movement, and often leads to prenatal or early infant death.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be associated with a particular condition, such as LCCS4. This type of testing allows for a more comprehensive analysis of the genetic code and can provide a more accurate diagnosis compared to traditional genetic testing methods.
If there is a suspicion of LCCS4 based on clinical symptoms, a healthcare provider may recommend NGS genetic testing to identify any variations or mutations in the MYBPC1 gene. This can help confirm the diagnosis and provide information for genetic counseling, family planning, and potential treatment options.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Dysmorphology
- Doctor: Pediatrics
- Test Department: Genetics
Pre Test Information
Before undergoing the MYBPC1 Gene Lethal Congenital Contracture Syndrome Type 4 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with MYBPC1 Gene Lethal Congenital Contracture Syndrome Type 4 NGS Genetic DNA Test gene MYBPC1.
This information will help in the accurate interpretation of the test results and provide valuable insights for genetic counseling, family planning, and potential treatment options.
At DNA Labs UAE, we are dedicated to providing accurate and comprehensive genetic testing services. Contact us today to learn more about the MYBPC1 Gene Lethal Congenital Contracture Syndrome Type 4 Genetic Test and how it can benefit you and your family.
Test Name | MYBPC1 Gene Lethal congenital contracture syndrome type 4 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Dysmorphology |
Doctor | Pediatrics |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MYBPC1 Gene Lethal congenital contracture syndrome type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYBPC1 Gene Lethal congenital contracture syndrome type 4 NGS Genetic DNA Test gene MYBPC1 |
Test Details |
The MYBPC1 gene is associated with a condition called lethal congenital contracture syndrome type 4 (LCCS4). LCCS4 is a rare genetic disorder characterized by multiple joint contractures, which restrict movement, and often leads to prenatal or early infant death. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be associated with a particular condition, such as LCCS4. This type of testing allows for a more comprehensive analysis of the genetic code and can provide a more accurate diagnosis compared to traditional genetic testing methods. If there is a suspicion of LCCS4 based on clinical symptoms, a healthcare provider may recommend NGS genetic testing to identify any variations or mutations in the MYBPC1 gene. This can help confirm the diagnosis and provide information for genetic counseling, family planning, and potential treatment options. |